Open-Label Phase I Clinical Study to Assess the Safety and Efficacy of Cilostazol in Patients Undergoing Internal Carotid Artery Stent Placement

Publisher： Karger

E-ISSN： 1664-5545|6|1-2|42-48

ISSN： 1664-9737

Source： Interventional Neurology, Vol.6, Iss.1-2, 2016-12, pp. : 42-48

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Efficacy and Safety of Oral Qing-Dai in Patients with Ulcerative Colitis: A Single-Center Open-Label Prospective Study

By  

Digestion, Vol. 93, Iss. 3, 2016-03 ,pp. : 193-201

Karger

Access to resources Recommend Favorite

A Long-Term Study of Acotiamide in Patients with Functional Dyspepsia: Results from an Open-Label Phase III Trial in Japan on Efficacy, Safety and Pattern of Administration

By  

Digestion, Vol. 84, Iss. 4, 2011-09 ,pp. : 261-268

Karger

Access to resources Recommend Favorite

An open-label long-term phase III extension trial to evaluate the safety and efficacy of pregabalin in Japanese patients with fibromyalgia

By Ohta Hiroyoshi   Oka Hiroshi   Usui Chie   Ohkura Masayuki   Suzuki Makoto   Nishioka Kusuki  

Modern Rheumatology, Vol. 23, Iss. 6, 2013-11 ,pp. : 1108-1115

Springer Publishing Company

Access to resources Recommend Favorite

An open-label pilot study of the efficacy and safety of anakinra in patients with psoriatic arthritis refractory to or intolerant of methotrexate (MTX)

By Jung Norma   Hellmann Matthias   Hoheisel Reimund   Lehmann Clara   Haase Ingo   Perniok Andreas   Hallek Michael   Rubbert Andrea  

Clinical Rheumatology, Vol. 29, Iss. 10, 2010-10 ,pp. : 1169-1173

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy and Safety of Galantamine in Patients with Dementia with Lewy Bodies: A 24-Week Open-Label Study

By  

Dementia and Geriatric Cognitive Disorders, Vol. 23, Iss. 6, 2007-04 ,pp. : 401-405

Karger

Access to resources Recommend Favorite